Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 Vaccine in Saudi Arabia

por Al Bahrani, Salma, Albarrak, Ali, Alghamdi, Othman Ali, Alghamdi, Mesfer Abdullah, Hakami, Fatimah H., Al Abaadi, Asmaa K., Alkhrashi, Sausan A., Alghamdi, Mansour Y., Almershad, Meshael M., Alenazi, Mansour Moklif, El Gezery, Mohamed Hany, Jebakumar, Arulanantham Zechariah, Al-Tawfiq, Jaffar A.
Publicado 2021

COVID-19 vaccine had a significant positive impact on patients with SARS-COV-2 during the third (Omicron) wave in Saudi Arabia

por AlBahrani, Salma, AlBarrak, Ali, Al-Musawi, Tariq, AlGubaisi, Nawal Ali, Almalki, Maram, Hakami, Fatimah H., Alghamdi, Turki, AlBeiuruti, Zena, Alkhrashi, Sausan, Almershad, Meshael, Alzahrani, Samira, AlQuraiaan, Amerah, AlTourifi, Helmy, Jebakumar, Arulanantham Zechariah, Al-Tawfiq, Jaffar A.
Publicado 2022

Self-reported long COVID-19 symptoms are rare among vaccinated healthcare workers

por AlBahrani, Salma, AlBarrak, Ali, AlGubaisi, Nawal, Alkurdi, Hamoud, Alburaiki, Dalia, AlGhamdi, Abdulrahaman, AlOthaiqy, Mohammed, Tayeb, Sarah, Tayeb, Nesreen, Abdraboh, Salimah, Khairi, Amani, Alshareef, Lujain, AlHarbi, Asma, AlRabeeah, Saad, Alqahtani, Abdullah S., Alqahtani, Jaber S., Hakami, Fatimah Hassan, Al-Maqati, Thekra N., Alkhrashi, Sausan Abdulrahman, Almershad, Meshael Musaed, AlAbbadi, Asmaa, Hakami, Mariam Hassan, Faqihi, Osama, Altawfiq, Kauthar Jaffar A., Jebakumar, Arulanantham Zachariah, Al-Tawfiq, Jaffar A.
Publicado 2023